Indiana Attorney General Todd Rokita is accusing Eli Lilly of conspiring with its competitors to artifically raise the price ...

Insulin is often cited as a prime example of soaring drug costs after years of price hike by drug manufacturers.

Oregon is joining cities, unions, and states across the country that have filed lawsuits alleging pharmacy benefit mangers ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

Oregon Attorney General Dan Rayfield filed a $900 million lawsuit against the nation's largest insulin manufacturers, ...

The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

For most healthy women, optimal fasting insulin levels should be less than 25 mIU/L (milli-international units per liter), ...

Oregon’s attorney general is suing six of the nation’s largest pharmaceutical companies and pharmacy benefit managers for ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

California will cap insulin co-pays at $35 and launch CalRx state-branded insulin in 2026 under new legislation signed by ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...